2017 American Transplant Congress Archives - Page 53 of 181

Early Results of the UK REVIVE Trial for Ex-Vivo Liver Warm Blood Perfusion of DCD and DBD Livers Using the Portable Organ Care System (OCS™) Liver Technology.

D. Vijayanand, F. Zahreldeen, J. Kingston, S. Farid, T. Mdlongwa, A. Ramsden, S. Willis, C. Moriarty, M. Attia.
Early Steroid Withdrawal and Infection in Kidney Transplant Recipients.

S. Bae, C. Durand, L. Kucirka, S. DiBrito, R. Avery, J. Garonzik Wang, D. Segev.
EBV-Specific CD8⁺ T Cells from Pediatric Thoracic vs Abdominal Transplant Recipients Are Shaped Differently by the Chronic EBV Loads with Potential Impact on the Risk of PTLD.

M. Yamada,^1,2 M. Camila,² P. Fadakar,^1,2 K. Hornor,¹ M. Michaels,^1,2 M. Green,^1,2 C. Nguyen,^1,2 B. Feingold,^1,2 G. Mazariegos,^1,2 D. Metes.²
Echinocandins in Lung Transplant Recipients (LTRs).

Y. AlJishi,¹ C. Rotstein,¹ D. Kumar,¹ A. Humar,¹ L. Singer,² S. Keshavjee,² S. Husain.¹
ECMO in Liver Transplant.

N. Goussous,^1,2 S. Hanish,¹ J. LaMattina,¹ Z. Kon,¹ D. Potosky,¹ J. Scalea,¹ W. Hutson,¹ R. Barth,¹ D. Bruno.¹
Ectopic Lymphoid Structures Are Present in Type I T-Cell Mediated Kidney Transplant Rejection.

K. de Leur,^1,2 M. Clahsen-van Groningen,³ G. de Graav,¹ D. Hesselink,¹ J. Samsom,⁴ C. Baan,¹ K. Boer.¹
Eculizumab Dose Reduction Is Safe by Monitoring Eculizumab Pre-Dose Level and Functional Complement Assays.

M. Gelens,¹ T. Havenith,² J. Damoiseaux,³ M. Christiaans.¹
Eculizumab Treatment on GC3 Recurrence on Renal Graft.

G. Jeantet,¹ D. Bertrand,³ A. Lionet,² D. Anglicheau,⁴ V. Fremeaux-Bacchi,⁵ M. Le Quintrec.¹
Educational Strategies for Increased Wait-Listing Rates: Opportunities for Dialysis Center Intervention.

A. Waterman,¹ J. Peipert,¹ H. Xiao,² C. Goalby,¹ K. Lentine.²
Effect of Academic Detailing with Prescribers as an Antimicrobial Stewardship Intervention in Solid Organ Transplant Patients.

M. So,¹ A. Morris,^1,2 C. Bell,² A. Humar,¹ S. Husain.¹